IMVT vs. XMMO
Compare and contrast key facts about Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO).
XMMO is a passively managed fund by Invesco that tracks the performance of the S&P MidCap 400 Index. It was launched on Mar 3, 2005.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IMVT or XMMO.
Correlation
The correlation between IMVT and XMMO is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
IMVT vs. XMMO - Performance Comparison
Key characteristics
IMVT:
-0.98
XMMO:
0.97
IMVT:
-1.41
XMMO:
1.47
IMVT:
0.84
XMMO:
1.18
IMVT:
-0.68
XMMO:
1.73
IMVT:
-1.57
XMMO:
4.79
IMVT:
27.51%
XMMO:
4.01%
IMVT:
44.33%
XMMO:
19.87%
IMVT:
-93.59%
XMMO:
-55.37%
IMVT:
-59.65%
XMMO:
-11.14%
Returns By Period
In the year-to-date period, IMVT achieves a -14.13% return, which is significantly lower than XMMO's -2.06% return.
IMVT
-14.13%
-9.10%
-34.39%
-42.51%
7.50%
N/A
XMMO
-2.06%
-8.76%
1.11%
15.92%
14.92%
14.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IMVT vs. XMMO — Risk-Adjusted Performance Rank
IMVT
XMMO
IMVT vs. XMMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IMVT vs. XMMO - Dividend Comparison
IMVT has not paid dividends to shareholders, while XMMO's dividend yield for the trailing twelve months is around 0.34%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IMVT Immunovant, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XMMO Invesco S&P MidCap Momentum ETF | 0.34% | 0.34% | 0.80% | 1.43% | 0.41% | 0.61% | 0.60% | 0.19% | 0.21% | 0.22% | 0.64% | 1.24% |
Drawdowns
IMVT vs. XMMO - Drawdown Comparison
The maximum IMVT drawdown since its inception was -93.59%, which is greater than XMMO's maximum drawdown of -55.37%. Use the drawdown chart below to compare losses from any high point for IMVT and XMMO. For additional features, visit the drawdowns tool.
Volatility
IMVT vs. XMMO - Volatility Comparison
Immunovant, Inc. (IMVT) has a higher volatility of 16.26% compared to Invesco S&P MidCap Momentum ETF (XMMO) at 5.83%. This indicates that IMVT's price experiences larger fluctuations and is considered to be riskier than XMMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.